Comprehensive analysis of breast cancer epidemiology, global burden, risk factors, and emerging research in prevention and treatment.
Discover how the ABTB2 regulatory variant rs6484711 predicts epirubicin-based chemotherapy response in Luminal A breast cancer patients.
Discover how differential allele-specific expression (DASE) analysis reveals breast cancer risk loci through gene imbalance in mammary epithelial cells.
Discover how circulating tumor cells and genome-wide copy number analysis are revolutionizing our understanding of breast cancer liver metastasis.
Explore how functional interrogation is transforming breast cancer treatment through genomics, CRISPR technology, and clinical trials like SERENA-6.
Discover how LAG-3, PD-1, and TIM-3 work together in breast cancer to suppress immune response and how combination therapies could overcome resistance.
Exploring how diverse participation in genetic studies is advancing precision medicine for breast cancer treatment and survival rates.
Research on the stepwise evolution of docetaxel resistance in breast cancer cells and emerging strategies to combat it.